👉 Delta Human Experiments, conducted by the National Institutes of Health between 2008 and 2012, aimed to evaluate potential new therapies for individuals with terminal illnesses by administering investigational treatments to participants who were terminally ill and lacked other options. These trials utilized a rigorous selection process and monitored both safety and preliminary efficacy data for novel drugs.
